Diffuse alveolar hemorrhage (DAH) is one of the complications of bone marrow or stem cell transplantation presenting as the idiopathic pneumonia syndrome (IPS).
Synonym: acute hemorrhage pulmonary edema, hemorrhagic alveolitis
Risk factors:
(1) non-HLA identical transplant
(2) graft vs host disease (GVHD), Grade II to IV
Onset: first 12-13 weeks (3 months) after transplant
Clinical features:
(1) progressive dyspnea
(2) cough
(3) hypoxemia
(4) hemoptysis rare
(5) fever may be present or absent
Broncho-alveolar lavage shows progressively bloodier aliquots.
Imaging features:
(1) diffuse pulmonary infiltrates (central appearance may be noticed initially)
Findings on lung biopsy:
(1) diffuse alveolar damage with intra-alveolar hemorrhage
Exclusion: infection, especially fungal pneumonia
The condition has a high mortality despite aggressively management.
Purpose: To evaluate a patient for diffuse alveolar hemorrhage (DAH) following bone marrow or stem cell transplant.
Specialty: Hematology Oncology, Surgery, general, Pulmonology
Objective: clinical diagnosis, including family history for genetics, complications
ICD-10: T86.0,